ストックスクリーナーアプリを入手
11.23
1.66%
-0.19
前日終値:
$11.42
開ける：
$11.58
24時間の取引高:
58,513
Relative Volume:
1.00
時価総額：
$153.07M
収益：
-
当期純損益:
$-8.89M
株価収益率:
-16.04
EPS:
-0.7
ネットキャッシュフロー:
$-6.48M
1週間 パフォーマンス:
+2.74%
1か月 パフォーマンス:
-9.07%
6か月 パフォーマンス:
-4.10%
1年 パフォーマンス:
-21.19%
1日の値動き範囲:
$11.20
$11.58
1週間の範囲:
$10.59
$13.00
52週間の値動き範囲:
$8.06
$15.50
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
名前
Greenwich Lifesciences Inc
セクター
電話
203-434-3290
住所
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
GLSI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
11.23 | 155.25M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-20 | 開始されました | Noble Capital Markets | Outperform |
| 2021-09-01 | 開始されました | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc (GLSI) 最新ニュース
Can Greenwich LifeSciences Inc. recover in the next quarterPortfolio Performance Summary & Consistent Growth Equity Picks - Newser
How to use a screener to detect Greenwich LifeSciences Inc. breakoutsTrade Risk Summary & Community Trade Idea Sharing - Newser
How sentiment analysis helps forecast Greenwich LifeSciences Inc.Quarterly Growth Report & Daily Oversold Stock Bounce Ideas - Newser
Smart tools for monitoring Greenwich LifeSciences Inc.’s price actionJuly 2025 Setups & AI Powered Market Entry Ideas - Newser
Tools to assess Greenwich LifeSciences Inc.’s risk profileJuly 2025 News Drivers & Stock Market Timing Techniques - Newser
Will Greenwich LifeSciences Inc. bounce back from current supportMarket Activity Report & Real-Time Market Trend Scan - Newser
Using Bollinger Bands to evaluate Greenwich LifeSciences Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Is Greenwich LifeSciences Inc. still worth holding after the dipJuly 2025 Update & Community Supported Trade Ideas - Newser
Measuring Greenwich LifeSciences Inc.’s beta against major indicesMarket Movement Recap & Stepwise Trade Signal Implementation - Newser
Quantitative breakdown of Greenwich LifeSciences Inc. recent moveAnalyst Upgrade & Breakout Confirmation Alerts - Newser
Is it time to cut losses on Greenwich LifeSciences Inc.Dividend Hike & Weekly Consistent Profit Watchlists - Newser
How moving averages guide Greenwich LifeSciences Inc. trading2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Combining price and volume data for Greenwich LifeSciences Inc.2025 Momentum Check & Smart Swing Trading Techniques - Newser
What the charts say about Greenwich LifeSciences Inc. today2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Is Greenwich LifeSciences Inc. stock reversal real or fake2025 Sector Review & Safe Entry Zone Tips - Newser
Custom strategy builders for tracking Greenwich LifeSciences Inc.2025 Sector Review & Daily Oversold Bounce Ideas - Newser
Short interest data insights for Greenwich LifeSciences Inc.Earnings Beat & Free Weekly Watchlist of Top Performers - Newser
How to track smart money flows in Greenwich LifeSciences Inc.July 2025 Levels & Real-Time Buy Signal Alerts - Newser
What to expect from Greenwich LifeSciences Inc. in the next 30 daysMarket Movers & Proven Capital Preservation Methods - Newser
Reversal indicators forming on Greenwich LifeSciences Inc. stockInflation Watch & AI Forecasted Stock Moves - Newser
Real time pattern detection on Greenwich LifeSciences Inc. stock2025 Year in Review & Daily Stock Trend Reports - Newser
Published on: 2025-09-11 23:20:16 - Newser
Analyzing net buyer seller activity in Greenwich LifeSciences Inc.Market Sentiment Summary & Technical Entry and Exit Tips - Newser
What Fibonacci levels say about Greenwich LifeSciences Inc. reboundEarnings Performance Report & Risk Controlled Swing Alerts - Newser
Sector ETF performance correlation with Greenwich LifeSciences Inc.Bond Market & Daily Technical Forecast Reports - Newser
FDA grants fast track designation to Greenwich LifeSciences’ breast cancer therapy - Investing.com India
Greenwich LifeSciences Inc. stock volume spike explainedOil Prices & Weekly Top Gainers Trade List - Newser
FDA Grants Fast Track Designation to GLSI-100 in HLA-A*02+, HER2+ Breast Cancer - OncLive
Nike, US chipmakers, Greenwich LifeSciences - TradingView
Greenwich LifeSciences jumps on FDA fast track for breast cancer therapy By Investing.com - Investing.com South Africa
Greenwich LifeSciences jumps on FDA fast track for breast cancer therapy - Investing.com Canada
Greenwich LifeSciences wins FDA Fast Track status (GLSI) - Seeking Alpha
Greenwich Lifesciences' GLSI-100 granted US FDA fast track designation - MarketScreener
Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation - GlobeNewswire
News impact scoring models applied to Greenwich LifeSciences Inc.July 2025 Drop Watch & AI Optimized Trading Strategy Guides - Newser
Greenwich Lifesciences Inc (GLSI) 財務データ
収益
当期純利益
現金流量
EPS
Greenwich Lifesciences Inc (GLSI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO |
Apr 17 '25 |
Buy |
8.98 |
5,400 |
48,492 |
5,567,002 |
| Patel Snehal | CEO and CFO |
Apr 07 '25 |
Buy |
9.10 |
3,600 |
32,760 |
5,561,602 |
| Patel Snehal | CEO and CFO |
Apr 04 '25 |
Buy |
8.73 |
5,500 |
48,015 |
5,558,002 |
| Patel Snehal | CEO and CFO |
Jan 10 '25 |
Buy |
12.51 |
2,500 |
31,275 |
5,552,502 |
| Patel Snehal | CEO and CFO |
Jan 07 '25 |
Buy |
13.75 |
1,800 |
24,750 |
5,550,002 |
| Patel Snehal | CEO and CFO |
Jan 06 '25 |
Buy |
13.31 |
1,100 |
14,641 |
5,548,202 |
| Patel Snehal | CEO and CFO |
Jan 03 '25 |
Buy |
12.95 |
3,400 |
44,030 |
5,547,102 |
| Patel Snehal | CEO and CFO |
Jan 02 '25 |
Buy |
11.97 |
2,000 |
23,940 |
5,543,702 |
| Patel Snehal | CEO and CFO |
Dec 31 '24 |
Buy |
11.36 |
2,400 |
27,264 |
5,541,702 |
| Patel Snehal | CEO and CFO |
Dec 30 '24 |
Buy |
11.12 |
3,200 |
35,584 |
5,539,302 |
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):